Clinical Trials Logo

Filter by:
NCT ID: NCT01885156 Completed - Tinea Cruris Clinical Trials

Evaluation of Efficacy and Safety of Naftin 1% Cream in Adolescent Subjects With Tinea Cruris

Start date: August 2013
Phase: Phase 3
Study type: Interventional

To see how well Naftin 1% cream works when applied once daily to the affected area. The results will be compared to those using a placebo cream, which is a cream with no active ingredient. Safety will also be measured.

NCT ID: NCT01501799 Completed - Acne Vulgaris Clinical Trials

A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduo™ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris

Start date: July 2011
Phase: N/A
Study type: Interventional

EPIDUO™ (adapalene and benzoyl peroxide) Gel 0.1%/2.5%, marketed by GALDERMA LABORATORIES, L.P., is a safe and effective topical therapy used for the treatment of acne vulgaris. Actavis Mid-Atlantic LLC has developed a generic formulation of adapalene and benzoyl peroxide topical gel 0.1%/2.5%,and the current study is designed to evaluate the safety and efficacy of this formulation to determine if it is bioequivalent to EPIDUO™.

NCT ID: NCT01396811 Completed - Tinea Pedis Clinical Trials

Topical Antifungal Treatment for Tinea Pedis

Start date: July 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine if a topical antifungal cream is safe and effective for the treatment of tinea pedis.

NCT ID: NCT01349998 Completed - Tinea Pedis Clinical Trials

Safety of a Topical Antifungal Treatment for Tinea Cruris, Tinea Pedis and Tinea Corporis

Start date: May 2011
Phase: Phase 3
Study type: Interventional

The purpose of this study is to examine the long-term safety of treating recurrent episodes of tinea pedis for 14 days for each recurrence and recurrent episodes of tinea corporis or tinea cruris for 7 days for each recurrence with Product 33525.

NCT ID: NCT01342315 Completed - Tinea Cruris Clinical Trials

Topical Antifungal Treatment for Tinea Cruris

Start date: May 2011
Phase: Phase 3
Study type: Interventional

To determine if a topical antifungal cream is safe and effective for the treatment of tinea cruris

NCT ID: NCT01182636 Completed - Acne Vulgaris Clinical Trials

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

Start date: July 2007
Phase: Phase 1
Study type: Interventional

The objective of this study was to evaluate the efficacy and safety of the test formulation of adapalene gel 0.1% (PLIVA Research & Development Ltd.) as compared to the already marketed formulation, Differin® (adapalene 0.1%) topical gel (Galderma Laboratories) in patients with acne vulgaris.

NCT ID: NCT00835510 Completed - Tinea Pedis Clinical Trials

Clinical Equivalence of Two Butenafine Hydrochloride 1% Creams in Patients With Interdigital Tinea Pedis

Start date: June 2008
Phase: Phase 1
Study type: Interventional

To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in the treatment of interdigital tinea pedis, and to show the superiority of the active treatments over that of the placebo (vehicle).

NCT ID: NCT00776919 Completed - Acne Vulgaris Clinical Trials

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

Start date: October 2008
Phase: Phase 3
Study type: Interventional

This is a Randomized, Double-Blind, Controlled Study to evaluate the Safety and Efficacy of a clindamycin / benzoyl peroxide gel in Subjects with Acne Vulgaris

NCT ID: NCT00689117 Completed - Acne Vulgaris Clinical Trials

A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel

Start date: April 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to demonstrate the safety and effectiveness of CT Gel in subjects with acne vulgaris. The hypothesis is that CT Gel is superior to Clindamycin Gel, Tretinoin Gel and Vehicle Gel for the treatment of acne vulgaris.

NCT ID: NCT00664248 Completed - Acne Vulgaris Clinical Trials

A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Start date: October 2006
Phase: Phase 3
Study type: Interventional

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.